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Abstract
The Bone Conduction Implant (BCI) system has been developed as an alternative to the
percutaneous bone anchored hearing aid (BAHA) with the advantage that the skin is kept
intact. The transducer is permanently implanted and attached to the skull via a flat sur-
face contact to the temporal bone. By applying amplitude modulation, the sound signal
is transmitted to the implanted transducer through the intact skin via an efficient wireless
inductive link. The external audio processor includes digital and analog signal process-
ing units, and an Application Specific Integrated Circuit driving the inductive link. Its
retention is provided by permanent magnets.
Preclinical investigations of the BCI system have been performed on a skull simula-
tor, a dry skull, cadaver heads and in an animal model study. In an extensive technical
evaluation using a skull simulator, it was found that the power output from the BCI sys-
tem was very robust for skin flap thicknesses from 2 to 8 mm with variability of less than
1.5 dB. Moreover, the peak of the maximum power output was 107 dB relative to 1 µN
at transducer resonance frequency and at 5 mm skin flap thickness. This means that the
highest output forces were produced in the ”normal” skin thickness range, which in fact
was one important design goal. The BCI system drains approximately 7.5 mA of battery
current at 1 kHz and at 65 dB input sound pressure level, which corresponds to a battery
lifetime of 5-7 days under normal use. It was found that significantly higher gain setting
can be used without feedback problems for the BCI as compared to the BAHA. In an ani-
mal model (sheep), it was found that the implant-to-bone attachment became firmer over
time and that the vibration transmission was stable over this period of eight months.
Finally, in a clinical study, the results of the first patient were reported at one month
follow up. The surgical procedure for installing the implant was found to be easy and safe,
and the BCI gave a significant improvement in hearing over the unaided condition. The
functional power output of the BCI was similar to most powerful ear level BAHA devices
on headband at lower frequencies and superior at higher frequencies. In summary, it was
found that the new BCI system can be an attractive alternative to the present percutaneous
BAHA system.
Keywords: Bone conduction implant, Bone anchored hearing aid, Implanted
transducer, Radio frequency power amplifier and inductive link, Amplitude modulation,
Low-power systems, Long-term implantation.
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Part I
Introductory chapters
1

Chapter 1
Introduction
This thesis presents the recent preclinical studies, clinical evaluation and technical
design and developments on a new implantable bone conduction hearing device.
Functionally deaf patients can gain normal hearing with this implant that replaces
the impaired middle ear. It requires a minor surgical procedure to insert a small
implant just behind the ear, under the skin and directly attached to the skull bone.
This new technique does not need any percutaneous implant and uses the skull
bone to transmit sound vibrations to the inner ear.
In view of the large number of problems and challenges in designing and de-
veloping implantable hearing devices, this thesis focuses on areas that will ad-
vance transcutaneous active bone conduction implants (BCI) for hearing impaired
patients. It will be described in greater details in the upcoming chapters that the
implanted bone conduction transducer needs to receive processed sound signal
and power wirelessly through intact skin. Furthermore, the transmission should
be designed to be very efficient to reach the desired output force levels in the
bone and also to consume as low power as possible. Efforts have been focused
on the design and development of the externally worn audio processor and the
implanted unit. The audio processor includes digital and analog signal process-
ing units and an efficient wireless power and data transmission system. To drive
the wireless link efficiently, an ultra low power Application Specific Integration
Circuit (ASIC) has been designed and fabricated for the BCI.
Another challenge that has been investigated during the design process is the
feedback limitations and maximizing the gain headroom for the BCI. The BCI
patients should be able to use the device with Full-on-Gain without falling into
oscillation and hollowing sounds. It was also very important to investigate the
long-term implant-to-bone surface in terms of vibration transmission efficiency
and linearity. Finally, the Medical Products Agency in Sweden and the Regional
Ethics Committee approved a clinical study in 2012, and today, six patients have
3
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Figure 1.1: Principal design of a generic percutaneous bone anchored hearing aid
(BAHA) with a screw attachment to the skull bone. It comprises a microphone (Mic),
battery (Bat) and pre and power amplifiers (Amp) that drive the bone conduction trans-
ducer.
successfully been implanted with the BCI. We believe that this device can improve
the quality of life for patients suffering from different hearing impairments and
make it available to use this technology all over the world.
It is reported in the World Health Organization (WHO) fact sheet that in 2013,
about 360 million people worldwide have a disabling hearing loss (Deafness and
hearing impairment Fact sheet N◦300, Updated February 2013). This shows the
great importance of improving the development of hearing devices to the society.
Whereas conventional hearing aids transmit sound to the tympanic membrane
via air conduction (AC), bone conduction (BC) devices transmit sound via vibra-
tions through the skull directly to the cochlea. In most hearing impaired patients
with conductive and mixed hearing loss and single sided deafness who can not
be rehabilitated by air conduction hearing aids, a conventional bone conduction
hearing device is an efficient alternative.
Major drawbacks with the conventional BC devices reported are the discom-
fort of the static pressure over the skin, reduced high frequency gain and feedback
problems. An alternative can be a direct bone conduction device with a permanent
skin penetrating titanium screw called the bone anchored hearing aid (BAHA) (see
Figure 1.1). Even though very successful implantations have been reported with
the BAHA, the permanent skin penetrating implant needs life-long commitment
of care every day. Skin irritation around the abutment may occur, and loss of
implant may happen as a result of trauma and skin infection.
4
A solution to these drawbacks can be the new bone conduction implant (BCI).
In the BCI the skin and subcutaneous tissue are kept intact by implanting the trans-
ducer within the skull bone close to the cochlea, which also might increase the
sensitivity of the bone conducted sound, see Ha˚kansson et al. (2010), Ha˚kansson
et al. (2008), Eeg-Olofsson et al. (2008), and Reinfeldt et al. (2014). In the BCI,
no screw attachment to the skull bone is used. Instead there is a flat direct con-
tact between the transducer casing and the skull bone. Moreover, the BCI has an
improved stability gain margine compared to the BAHA that allows for the possi-
bility to increase the real gain of the BCI without getting feedback problems, see
Taghavi et al. (2012c).
1.1 Aim of thesis
The main aim of this thesis project was to design and develop a new BCI system
that could be used for long term implantation in the indicated patients. This main
aim is broken down in several sub projects:
• To investigate if a first prototype BCI system attached to cadaver heads is
sufficiently powerful with reference to a standard BAHA device attached to
the same heads (Paper I).
• To design an efficient inductive link for power and signal transmission through
the intact skin (Papers II, III). The final solution should be implemented in
an ultra low power Application Specific Integrated Circuit (part of Paper
VI).
• To investigate the stability gain margins with a BCI device attached to a
dry skull and compare with the stability gain margins using a BAHA on the
same skull (Paper IV).
• To investigate in an animal model how a flat surface contact between im-
plant and bone will develop over time (Paper V).
• To develop and verify the performance of a full BCI system to be used on
patients (Paper VI).
• To evaluate the full BCI system on a first patient in an approved clinical
study (Paper VII).
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1.2 Thesis outline
Chapter 2 briefly describes the hearing physiology in humans and explains the
hearing by air and bone conduction and the hearing impairments. An overview
on the recent developments of bone conduction devices and the future devices are
described with more details and illustrations in Chapter 3. Next, in Chapter 4, a
summary of the papers is presented. Finally, Chapter 5 includes a summary of the
project achievements in terms of main conclusions and suggestions of future work
of the BCI device.
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Chapter 2
Hearing physiology
2.1 Hearing by air and bone conduction
The primary function of the ear is to receive sound from environment and con-
vert it into neural information that can be perceived by brain. As the sound goes
through different parts of the auditory system, the sound energy is mechanically
transformed. This process is called the transduction process. Basic structure of
the human ear including outer ear, middle ear and inner ear organs are illustrated
in Figure 2.1.
pinna
earcanal
tympanic
membrane
malleus
incus
stapes
middle ear ossicles
semicircular
canals
cochlea
oval
window
round
window eustachian
tube
vestibulum
concha
Figure 2.1: Basic structure of the anatomy of the human ear showing outer ear, middle
ear and inner ear organs.
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2.1.1 Air conduction hearing
In air conduction hearing, the outer ear is the primary connection between the
sounds in the environment and the middle ear. The outer ear is important in pro-
tecting middle and inner ear structures, and it modifies the incoming sound prior
to arrival at the tympanic membrane and provides some cues for sound local-
ization from the front, back and overhead (Gelfand, 2001). Moreover, the outer
ear amplifies the sound pressure through the mechanism referred to as the ear
canal resonance with about 15-20 dB in the frequency range of 1.5 to 7 kHz (Bal-
lachanda et al., 1995) before arriving at the tympanic membrane. The middle ear
is a mechanical system, which transforms the acoustical vibrations at the tym-
panic membrane into mechanical vibrations of the ossicular chain. The ossicular
chain delivers the vibrations directly to the oval window.
One primary function of the middle ear is to overcome the energy loss due to
air-to-fluid impedance mismatch. The middle ear is hence a mechanical amplifier
and performs the amplification in three ways. The largest amplification is due
to the size differences between the tympanic membrane and the oval window,
referring to the area ratio and gives at maximum nearly 25 dB of gain (Kramer
et al., 2008). The second amplification mechanism is called the curved membrane
advantage and is related to the cone shape of the tympanic membrane, which gives
about 6 dB increase in pressure at the oval window. The third mechanism is the
lever advantage of the ossicular chain that increases the gain about 2 dB (Kramer
et al., 2008). The transfer function for the middle ear shows in total approximately
20-25 dB increase in pressure at the oval window in a wide frequency range and
especially effective in the low to middle frequency (von Be´ke´sy, 1955; Møller,
1963). Two small middle ear muscles offer some protection to the ear from loud
sounds, called the acoustic reflex.
Processing of the sound in the inner ear starts with the movement of the stapes
footplate in the oval window. These mechanical pressure variations of the middle
ear ossicles are transformed into pressure variations in the fluid. Furthermore, the
pressure variations in the cochlea cause the basilar membrane to move, resulting
in a travelling wave. Finally, as the basilar membrane is narrower and stiffer in the
base and widens and becomes less stiff towards the apex, it permits a frequency
separation along its length.
The vibrations deliver the sound wave pattern to the inner ear with the fluid
in the upper and lower cavities (scala vestibuli and scala tympani) of the cochlea.
This travelling vibration wave results in bending of the stereocilia, providing in-
creases and decreases of ions (e.g. Potassium ions (K+)) into the inner and outer
hair cells, changing the intracellular potentials. The chemical-to-neural transduc-
tion occurs at the chemical synapse between the inner hair cells’ membranes and
the peripheral afferent auditory neurons. The inner hair cells control the release of
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neurotransmitter substance. The outer hair cells increase the sensitivity, sharpen
the tuning, and are responsible for the sharp tip region of tuning curves. They
are the acoustical preamplifiers. These waves cause a motion of the hair cells
supported by the basilar membrane. Each frequency of the sound wave affects a
particular part of the basilar membrane and stimulates a response of the hair cells
at that location. High frequency sounds cause enhanced movements of the cells
near the base of the cochlea and lower frequencies produce enhanced movements
near the tip of the cochlea. Hair cells in the basilar membrane move relative to the
tectorial membrane, displacing the cilia on the hair cells. It results in a chemical
reaction within the hair cells triggering electrical responses in the auditory nerve.
The louder or intense the sound, the more impulses are generated. These electri-
cal impulses travel through the auditory nerve to different sound signal processing
parts of the brain, which interprets the sound. This interpretation takes place in
the auditory cortex located in the temporal lobes on each side of the brain. Most
of the sorting, processing and sensation of the sound occur in the gray matter. In-
teraction between the right and the left sides takes place as cross talk in olivary
nuclei along the nerve pathways to the brain and in the temporal lobes. This anal-
ysis has a role in background noise suppression and allowing a person to focus on
the desired sounds.
If the outer hair cells are damaged, the active process in the cochlea is com-
promised and mild-to-moderate degrees of hearing loss occur. For greater degrees
of hearing loss, there is additional damage to the inner hair cells.
The peripheral hearing mechanism includes both the conductive and sensorineu-
ral mechanisms. The conductive mechanism involves the outer and middle ear,
sensorineural mechanism includes the inner ear and the auditory nerve. In the
central auditory mechanism, the central auditory pathway to the brain is involved.
2.1.2 Bone conduction hearing
The bone conduction hearing is the process of transmitting sound energy with
vibrations through the skull directly to the cochlea. This results in an auditory
sensation and hearing. Bone conduction hearing is the secondary auditory path-
way that supplements the air conduction process. The sound waves are impacting
the human skull either directly from the surrounding environment, by direct me-
chanical stimulation of the skull by a vibratory source, or from one’s own voice.
Main air conduction and bone conduction hearing paths are illustrated in Fig-
ure 2.2. The main difference between hearing through air conduction and bone
conduction is how sound is transmitted to the cochlea. In the air conduction pro-
cess, sound energy travels in a unidirectional path through the external ear canal,
vibrates the tympanic membrane, travels across the ossicular chain and creates
movements of the stapes against the oval window of the cochlea.
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Figure 2.2: Bone conduction and air conduction paths: blue path represents the air con-
duction part of the one’s own voice, red path shows the bone conduction part of one’s own
voice and from an implanted BCI transducer (Reinfeldt, 2009).
In bone conduction, the whole or a part of the skull vibrates, and depending
on the direction of the stimulation, vibrations may also be reflected backwards
from the cochlear fluid. The vibrations of the skull coming from different direc-
tions will add together to vibrate the fluids in the cochlea (Henry, 2007). At the
cortical level, a 1 kHz tone at a patient’s threshold of hearing has the same neural
representation regardless of the mode of stimulation, whether it is air conducted
or bone conducted (von Be´ke´sy, 1955). However, there are many differences be-
tween the input levels of BC and AC excitations that are needed for generating
the same neural representation to the patient (Hodgetts, 2009). The efficiency of
the BC hearing is largely dependent on the skull bone where the skull acts as a
rigid body at low frequencies, and includes different types of wave transmission
at higher frequencies (Stenfelt, 2011).
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There exist several contributing factors in the bone conduction hearing process
and the most important ones are (Stenfelt and Goode, 2005):
• Sound radiated in the ear-canal
• Middle ear ossicle inertia
• Inertia of the cochlea fluids
• Compression of the cochlear walls
• Pressure transmission from the cerebrospinal fluid
The inertia of the cochlear fluid is the most dominant contributor below 4 kHz
and may be less important at higher frequencies. Middle ear ossicle inertia influ-
ences the BC sensitivity in the mid-frequencies between 1.5 and 3.1 kHz (Stenfelt,
2006).
2.2 Hearing impairments
Hearing impairment or hearing loss is a full or partial loss in the capability of
detecting and understanding sounds. It can be due to biological or environmen-
tal factors. Hearing losses are divided into three different types of impairments:
conductive loss, sensorineural loss and mixed hearing loss.
Conductive hearing loss occurs when the sound is not properly conducted
through the outer ear, middle ear or both. In this case, the sound can still be
detected by the inner ear with a functional cochlea. The sensorineural loss can
be divided into cochlear losses and losses in the auditory nerve or brain, which
sometimes also are referred to as retrocochlear hearing loss. Hence, the cochlea
or the nervous system loses their sensitivity to the sound. The great majority of
human sensorineural hearing losses are caused by noise induced or hereditary ab-
normalities in the hair cells of the organ of Corti in the cochlea. On top of these
impairments there are also significant deteriorations by age known as presbyacu-
sis, which is a progressive, bilateral symmetrical, sensorineural hearing loss.
Mild-to-profound sensorineural and age-related hearing losses can be rehabili-
tated by air conduction hearing aids. Moreover, cochlear implants provide a sense
of sound to poeple who are profoundly deaf or severly hard of hearing. However,
for conductive and mixed hearing loss, and certain ear canal and middle ear dis-
orders (e.g. congenital malformations, chronic ear infections, draining ears, and
eczema in the ear canal) bone conduction devices are used for rehabilitation.
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Chapter 3
Recent developments of bone
conduction devices
In this chapter, an overview of the present and future bone conduction devices will
be given. The field of bone conduction hearing devices is growing dramatically
and it is of the most importance to categorize them in an appropriate manner to
figure out and interpret their similarities and differences. Whereas hearing devices
in general may be classified as six major categories, bone conduction devices can
be classified in three sub categories; skin drive, direct drive, and in-the-mouth
device, respectively. A summary of hearing device classification follows:
• Air conduction hearing aids,
• Bone conduction devices (BCD),
– Skin drive
∗ Conventional BCD - on headband or eyeglasses
∗ Transcutaneous passive BCD - implanted retention magnet
– Direct drive
∗ Percutaneous bone anchored hearing aid (BAHA)
∗ Transcutaneous active BCD - implanted transducer
– In-the-mouth device
• Middle ear implants (MEI),
• Direct acoustic cochlear implants (DACI),
• Cochlear implants (CI), and
• Auditory brainstem implants (ABI).
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Our main focus in this chapter will be on the developments of the bone con-
duction devices, and hence the classification of the BCDs will be based on how
they drive and stimulate the bone, whether they are skin drive, direct drive or in-
the-mouth devices. In the skin drive category, the vibrating transducer is pressed
against the skin by using a soft band or steel spring. This is called the conventional
bone conduction device. It can also be attached to the skin by using a retention
magnet system where one magnet is implanted under the skin and one is placed
in the external unit. With both types of attachment, the vibrations are generated
by the externally worn transducer and transmitted through the intact skin and then
to the skull bone. In the direct drive BCD category, the vibrations are directly
transmitted to the skull bone. The vibrations can go through a skin penetrating
implanted titanium screw, such a system is called the percutaneous bone anchored
hearing aid (BAHA). On the other hand, if the transducer is implanted into the
skull bone under the skin and sound is wirelessly transmitted, it is called the tran-
scutaneous active bone conduction device.
All these BCDs use electromagnetic transducers. There is another type of
BCD that transmits the vibrations to the teeth and uses a piezoelectric transducer,
which is called the SoundBite system. In the following the conventional bone con-
duction device, the transcutaneous passive systems (Sophono and Baha Attract),
the bone anchored hearing aids, the transcutaneous active systems (Bonebridge
and BCI), and the SoundBite will be presented. The advantages and drawbacks of
each device will be shortly discussed.
3.1 Skin drive bone conduction devices
3.1.1 The conventional bone conduction device
In air conduction (AC) hearing aids, the sound is collected from the environment
by a microphone and then fed to the amplifier and the sound processor. The am-
plifier will increase the intensity of the sound to a desired level and then the pro-
cessed sound will be sent to the output miniaturized loudspeaker. A conventional
bone conduction device has the same microphone, processing and amplifier parts
as conventional AC hearing aids, except that the loudspeaker is replaced by a
bone conduction transducer. The BC transducer can be connected to a flexible
headband or onto the earpiece of a pair of eyeglasses. As the vibrations here are
transmitted through the skin and subcutaneous tissue, this mode of transduction
often is referred to as transcutaneous BC. The primary and major problem with
conventional BC hearing devices, those applied with headband as well as with
frames of a pair of glasses, is related to the static pressure force (F) of a couple
of Newton (typically 2 N) (von Be´ke´sy, 1960) towards the skin and the soft tissue
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that is needed to transmit the vibration energy through skin to the bone (see Figure
3.1).
This often gives the patient discomfort and the skin can suffer from circulatory
problems and sometimes irritation and eczema are developed. Recent develop-
ments to use low capillary pressure show how these comfort aspects can be im-
proved (Raicevich et al., 2008). Developments have been done by a Danish com-
pany Ortofon (http://ortofonmicrotech.com) using a new smaller BC transducer
based on the Balanced Electromagnetic Separation Transducer (BEST) princi-
ple (Ha˚kansson, 2003). The housing is designed to reduce the capillary pressure
and the transducer impedance is matched with the power amplifier and battery
impedances. A secondary problem is related to the dampening effect of the skin
that attenuates the transmission sensitivity at higher frequencies, essentially over
2 kHz. This reduces the electroacoustical function of the aid (Ha˚kansson et al.,
1984). Yet another problem is related to acoustic feedback, where the aerial sound
is radiated from the transducer back to the microphone; this causes howling and
ringing sound (oscillations) and as a consequence the microphone must be placed
on a safe distance from transducer. The development of conventional BCDs is
important as they can be used for the youngest children where surgery and im-
plantation is not recommended.
BH
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Figure 3.1: Conventional bone conduction device with static pressure force (F) against
the patient’s skin sometimes referred to as transcutaneous BCD. The blue dash arrow
represents the vibration transmission path from the transducer, through the skin and soft
tissue into the skull.
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3.1.2 Transcutaneous passive BCD
The Sophono system
A new semi-implantable transcutaneous passive bone conduction device without
a percutaneous abutment was suggested by Siegert (2011). This device is known
as the Sophono (originally Otomag) system, and its principle (illustrated in Fig-
ure 3.2) is a magnetic coupling and acoustic transmission between implanted and
external magnets. In this system the transducer is optimized for maximum elec-
tromechanical transduction generically identical to the transducer used in conven-
tional BCD. The implanted magnet system, with dual magnets attached to the
skull bone using five screws, is thus solely used for retention of the external trans-
ducer with the intact skin in between. It should be noted that the vibrations of the
transducer case or plate are still transmitted by vibrations through the soft tissues
(thinned skin to 4-5 mm thickness, Siegert (2011); Siegert and Kanderske (2013))
and hence it is a trancutaneous passive BC device. Magnets are implanted into
shallow bone beds in a 1-stage procedure. The external device is then fixed with
counter magnets in a base plate.
S
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Figure 3.2: The Sophono system with a conventional external BC transducer that is held
in place by use of an implanted retention magnet system.
As a consequence one might expect that there is a high frequency transmission
loss of energy like as in conventional BCD as compared to a percutaneous system.
One might also expect that the skin in the contact area is under constant pressure,
which might cause some wearing comfort problems and that there is a potential
risk for circulatory problems. According to manufacturer (Sophono, 2013), pa-
tients with conductive and mixed hearing loss with hearing thresholds better than
45 dB HL can receive the implant. The average hearing gain in free field using
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pure tones has been reported by Siegert and Kanderske (2013) to be 31±8 dB
in patients with congenital ear canal atresia. The strength of magnetic force that
has been chosen by these patients was 0.9 ± 0.4 N with a range of 0.3 to 1.8 N.
Skin flap thickness over the implants has been measured sonographically and was
found to be 3.9 ± 0.8 mm with a range of 2.5 to 5.6 mm.
In a study by Sylvester et al. (2013) on both adults and children it was shown
that the average gain was greatest for those with bilateral conductive loss (21.9 ±
10.4 dB HL). For those with bilateral and unilateral mixed hearing loss, average
gain was 6.2 ± 5.3 dB HL and 5.5 ± 6.5 dB HL, respectively. All measure-
ments were done by Sophono Alpha 1(M) device. The Sophono device has been
also implanted in children and the priliminary results show that the mean gain
was 43 ± 6.96 dB (Denoyelle et al., 2013). In a study done by Hol et al. (2013)
in children the Sophono-based results were compared with BAHA-based device.
The BAHA-based outcomes were slightly better than the Sophono-based device
results in sound field thresholds, speech recognition thresholds and speech com-
prehension at 65 dB sound pressure level (SPL). In terms of mechanical output of
the devices, BAHA has 10 to 15 dB higher output measured on a Skull simula-
tor. In all of these studies, only minor skin irritations have been reported. These
results are ambiguous as gain varies from 6.2 dB and 21.9 dB (Sylvester et al.,
2013) to 43 dB (Denoyelle et al., 2013) and therefore more rigorous audiometric
evaluations are called for. Sophono devices received clearance from the U.S. Food
and Drug Administration (FDA) and American Society for Testing and Materials
(ASTM) International for their patients with the Alpha 1 or 2 systems to be able
to undergo MRI in both 1.5 and 3 Tesla magnetic fields without removing the
magnetic implant.
This system might be an alternative to a conventional BCD as its externally
worn transducer is more precisely attached to one and the same spot of the pa-
tient’s skull bone day after day. This system might be more aesthetically appeal-
ing than a conventional BC device as no steel spring is needed. As usual one has
to balance these potential advantages against the more invasive surgery required
and increased cost. If transcutaneous passive BCDs are powerful enough, they
might also provide a solution to minimize the adverse events and implant loss in
percutaneous devices.
The Baha Attract system
Cochlear Baha Attract system (Cochlear Bone Anchored Solutions, Mo¨lnlycke,
Sweden) is a new transcutaneous passive BCD where the sound is transmitted as
vibrations from an external sound processor through the intact skin to an internal
magnet attached to the same type of screw fixture used for the BAHA. Cochlear
Baha Attract system is CE marked and FDA cleared and is aimed for patients with
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Figure 3.3: The Baha Attract system with a Baha external sound processor that is held in
place by use of an implanted retention magnet system.
conductive hearing loss and single-sided sensorineural deafness (SSD) in the im-
planted ear with pure tone average BC thresholds below 30 dB HL (Baha-Attract,
2013). Principal design of the Baha Attract system is shown in Figure 3.3. The
implanted magnet is attached to the skull bone by a BAHA fixture. The magnet
is of a circular shape of diameter 27 mm and thickness of 1.5 mm. The implant
is MRI conditional up to 1.5 Tesla. The sound processor magnet has a soft pad
made of slow recovery memory foam to distribute the static force over the skin.
The device is suitable for skin thicknesses between 3 to 6 mm. Contact pressure
is measured and reported to be less than 0.4 N/cm2, which corresponds to a total
force of 2.3 N. It has been shown in a preliminary results that the Baha Attract is
slightly better than the Baha on headband, but still weaker than percutaneous Baha
(Flynn et al., 2013). Clinical data is still missing from multicenter investigators,
but is anticipated in a near future.
3.2 Direct drive bone conduction devices
3.2.1 The bone anchored hearing aid (BAHA)
As an alternative to the conventional BC devices the bone anchored hearing aid
(BAHA) that uses a permanent skin penetration was installed in the first patient
in 1977 (Tjellstro¨m et al., 1983). The BAHA has a titanium fixture that is an-
chored to the skull bone and the output transducer is coupled to the implant. The
sound is transmitted directly from the vibrator to the skull bone (Ha˚kansson et al.,
1985). This type of vibration transmission obtained with the BAHA is sometimes
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Figure 3.4: Principal design of a generic percutaneous bone anchored hearing aid
(BAHA) with a screw attachment to the skull bone. Moreover, it comprises a microphone
(Mic), battery (Bat) and pre and power amplifier (Amp) that drives the bone conduction
transducer.
referred to as Direct Bone Conduction (DBC). DBC hearing opened possibili-
ties for an improved rehabilitation of patients both in terms of wearing comfort
and sound quality (Ha˚kansson et al., 1990; Tjellstro¨m et al., 2001). Figure 3.4
illustrates the principal design of the BAHA device. Today, the BAHA is the
golden standard in many countries for patients with chronic middle ear diseases
and congenital malformations, and who cannot use air conduction hearing aids.
The surgery is uncomplicated and safe for patients and more than 100,000 pa-
tients have been operated for the BAHA (Cochlear, 2013). A summary of the
current candidacy criteria, and audiological and surgical considerations of the
present BAHA system, is given by Snik et al. (2005) and Hodgetts (2010). Pa-
tients with BC thresholds less than 55 dB HL averaged across 500, 1000, 2000,
and 4000 Hz are candidates for the most powerful BAHA. More information can
be found at the two companies’ websites, who are producing the BAHA systems;
Cochlear Bone Anchored Solutions (http://www.cochlear.com/) and Oticon Medi-
cal (http://www.oticonmedical.com/). Even though there are very good long-term
rehabilitation results reported with the BAHA (see for example Snik et al. (2005)),
there are also some known associated complications.
One main drawback is related to the fact that the skin penetration site needs
lifelong daily care. Some patients may acquire a skin reaction with persistent in-
fection and also granulation tissue may be formed that requires surgical revision
or re-implantation. Also, the bone anchored fixture can be lost spontaneously es-
pecially in children (de Wolf et al., 2008, 2009) or as a result of trauma. There
are a number of potential BAHA patients that reject a BAHA because they can-
not accept a skin penetration implant for aesthetic reasons. See also Tjellstro¨m
and Granstro¨m (1994), Myers et al. (2000), Battista and Littlefield (2006), Shi-
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razi et al. (2006), Wazen et al. (2011), and Dun et al. (2012) for a more detailed
description of potential complications associated with the permanent skin penetra-
tion. To overcome some of these complications, several developments are under
evaluation (Ha˚kansson, 2011; Dun et al., 2011). Finally, it should be mentioned
that the gain of the BAHA has been limited to maintain stability and reduce feed-
back problems that causes oscillations mostly in higher frequencies; this implies
that the stability gain margin is lower than desired (Taghavi et al., 2012c).
3.2.2 Transcutaneous active BCD
The bone conduction implant (BCI)
A new semi-implantable transcutaneous active solution, called the bone conduc-
tion implant (BCI), has been proposed and developed in a cooperation project be-
tween Chalmers University of Technology and Sahlgrenska Academy, University
of Gothenburg, Sweden, and introduced as an alternative to percutaneous BAHA
(Ha˚kansson et al., 2008, 2010; Ha˚kansson, 2011; Taghavi et al., 2012b,a; Eeg-
Olofsson et al., 2013). In the BCI, skin and subcutaneous tissue is kept intact and
there is no screw attachment to the skull bone. Furthermore, the BCI transducer
is implanted in the skull bone, closer to the cochlea compared with the BAHA,
which increases the sensitivity to the bone conducted sound (Ha˚kansson et al.,
2008, 2010; Stenfelt et al., 2000; Stenfelt and Goode, 2005; Eeg-Olofsson et al.,
2008; Reinfeldt et al., 2014). A principal design of a trancutaneous direct bone
conduction device with an implanted transducer is shown in Figure 3.5a. Figure
3.5b shows the BCI device with audio processor and implanted unit.
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Figure 3.5: (a) Principal design of the full-scale BCI with an implanted and capsuled bone
conduction transducer with a flat surface contact to the skull bone. (b) The BCI device
with the audio processor, receiver coil, transducer and demodulator unit. The implanted
unit is sealed and molded in medical implant grade silicon.
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The generic feature of this systems is that the skin is kept intact and it is the
sound signal that is transmitted transcutaneously by a magnetic inductive system
from the external processor to the implanted transducer, which is attached directly
to the skull bone. Hence, it is the electric/magnetic signal that is transmitted
transcutaneously (not the vibration) and the vibrations are still induced directly to
the skull bone with direct drive bone conduction like in the BAHA.
In Papers II and III, Taghavi et al. (2012b,a) has proposed analog and switch-
ing RF data and power link designs for the BCI to produce the highest possible
output force level and fairly robust power transmission for different skin thick-
nesses.
In principle a BCI system has obvious technical challenges, which are related
to:
• placement and type of attachment of the implanted transducer,
• design of the implanted transducer,
• design of the RF inductive link, and
• design of the RF power driver.
It was discussed that this system will suffer from losing too much power in the
inductive link, difficulties to screw attach the transducer and vulnerability and too
big a size of the implanted transducer. However, several studies have shown dif-
ferent challenges where the results look promising (Ha˚kansson et al., 2008, 2010;
Ha˚kansson, 2011). It has been shown on cadavers that the sensitivity to bone-
conducted sound would increase if the excitation point approaches cochlea, which
is the case in the BCI device position comparing with the BAHA position (Stenfelt
et al., 2000; Stenfelt and Goode, 2005; Eeg-Olofsson et al., 2008; Ha˚kansson et al.,
2010; Reinfeldt et al., 2014). Moreover, it was shown by Taghavi et al. (2012c)
in Paper IV that the BCI device has an improved gain headroom compared with
the BAHA. In an animal study by Taghavi et al. (2013) on the flat surface contact
of the BCI transducer housing to the skull bone in sheep, it was shown that the
vibration transmission remains stable and linear over time. All the developments,
studies and promising results have been our driving force to apply for a clinical
trial for the BCI system. In fall 2012, the BCI got approved for a clinical trial
of 20 patients from Regional Ethics Committee and the Swedish Medical Device
Agency. So far six patients have been operated, got their audio processors and
are now attending the follow-up measurements. Figure 3.6a shows the implanted
BCI transducer attached to the skull bone using a titanium wire. Preoperative and
post operative cone beam computed tomography and a virtual planning tool has
been used to optimize and control the position of the BCI in the mastoid. The
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cone beam computed tomography of the implant ten days after surgery is shown
in Figure 3.6b and the patient who is wearing the audio processor without any
skin problem is shown in Figure 3.6c. First implantation, surgical and audiologi-
cal results of the BCI has been published by Eeg-Olofsson et al. (2013) showing
that on average, the tone thresholds improved by approximately 30 dB and speech
reception thresholds by 25.5 dB. Final technical design of the BCI is reported by
Taghavi et al. (2014) that will be submitted this year (Paper VI).
(a) (b) (c)
Figure 3.6: (a) The BCI implanted transducer in the temporal bone with constant attach-
ment force provided by a titanium wire, (b) cone beam computed tomography ten days
after surgery, and (c) patient who is wearing the audio processor.
The Bonebridge system
The Bonebridge is a new implantable direct drive transcutaneous active BCD pro-
duced by MEDEL Vibrant (http://www.medel.com/), in which the implanted unit
is positioned completely under the skin. The implant receives the signals from
an externally worn audio processor that is attached to patient’s head, behind the
ear, and is kept in position over the implant by magnetic force. The implanted
part consists of a receiver coil, a magnet, a demodulator and the bone conduction
floating mass transducer (BC-FMT) as shown in Figure 3.7.
The sound signal and energy to drive the transducer are transferred transcu-
taneously via an inductive link. The BC-FMT is attached to the bone by cortical
fixation screws. For signal transmission, osseointegration of the cortical screws is
expected, but not crucial. Magnetic resonance imaging with up to 1.5 Tesla can
be carried out with a Bonebridge implant (Sprinzl et al., 2013), provided that the
external processor is not worn. Indication range for the Bonebridge is set to the
bone conduction threshold levels not worse than 45 dB HL for the frequencies of
500 through 4000 Hz. It is suitable for people who suffer from conductive hearing
loss, mixed hearing loss or single-sided deafness.
It has been shown by Sprinzl et al. (2013) that the speech perception as mea-
sured by word recognition scores in quiet and speech threshold recognition of
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Figure 3.7: The Bonebridge system with an implanted unit including receiver coil and a
magnet in the center, demodulator circuit and BC-FMT transducer. The audio processor
is held in place by magnetic attraction, receives the sound and converts it into signals,
which are then transferred through the skin to the implant.
50% (SRT50%) improved relative to unaided on average about 78.8% and 25 dB,
respectively three months after implantation. Some minor adverse events were re-
ported. In another study that was done on mixed hearing loss patients by Barbara
et al. (2013), it was shown that the average improvement of the SRT in quiet with
Bonebridge compared to unaided was 36.25 dB. It has been shown in a study by
Lassaletta et al. (2013) that the unaided thresholds of 68 dB HL improved to aided
thresholds of 25 dB HL, and that speech discrimination scores improved 35% in
a patient with chronic otitis media. Tsang et al. (2013) has also reported in an
Asian patient experience that the functional gain of using Bonebridge varied from
minimum of 10 dB to a maximum of 40 dB.
3.3 In the mouth bone conduction device
It is well-known that BC sound can be induced by the transducer attached to
the teeth. Also, a significant part of one’s own voice is heard via the teeth and
jaw (Reinfeldt, 2009; Reinfeldt et al., 2010) so this route is definitely viable
for transmission of bone conducted sound. The major advantage to attach the
transducer to the teeth for long term hearing rehabilitation compared with the
direct drive BC systems is that it is completely non-invasive. Several develop-
ments on this idea have been done and the intraoral device from Sonitus Medical
(http://www.sonitusmedical.com) has been commercially available in the US and
EU. This device is called the SoundBite Hearing System and is intended for pa-
tients who suffer from single sided deafness or conductive hearing loss. It con-
sists of both a behind-the-ear (BTE) microphone unit, housing the receiver, wire-
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Figure 3.8: SoundBite device. The sound is picked up by an external microphone, worn
behind the ear and is then transmitted wirelessly to the (In-The Mouth) hearing device
attached to the teeth. The piezoelectric transducer converts the sound to vibrations that
travel via the teeth, through the bone to the cochlea.
less transmitter, and attached microphone, and a discrete, removable in-the-mouth
(ITM) hearing device that is attached to the upper left or right back teeth, princi-
pally illustrated in Figure 3.8.
It should also be noted that the sound here has to be picked up by an external
tiny microphone that is placed within an open fit dome worn in the canal of the
impaired ear and connected to the BTE microphone unit by a small translucent
tube as also illustrated in Figure 3.8. The BTE should then transmit the sound
wirelessly to the internal device attached to the teeth. Sound vibrations are then
conducted via the teeth, through bone, to the cochleae. Initial evaluations of this
system have been made by Popelka (2010) and Popelka et al. (2010). Efficacy
and long-term safety of the device has been evaluated by Murray et al. (2011a,b);
Gurgel and Shelton (2013). It has been shown that the device is safe and effective
and provides substantial benefit for SSD patients.
However, even if this idea from an electro acoustical point of view will work,
one might be wondering how convenient it will be to wear the device in the mouth
during one normal day. For single sided deaf patients this device may from acous-
tical point of view be a good alternative as these patients only need high frequency
gain to overcome the head shadow effect and in that frequency range the trans-
ducer can be designed to consume less power. If this device should be aimed for
those having conductive and mixed hearing loss, there might be a power issue at
low frequencies.
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The SoundBite transducer has a relative low power output below 1 kHz as
compared to the BAHA and the BCI systems (see Fig 2 in Popelka et al. 2010).
Moore and Popelka (2013) have compared the effectiveness of the BAHA and
the SoundBite in unilateral hearing loss patients. It was shown that the speech
perception and sound localization were similar for both devices, but the SoundBite
led to lower mid-frequency aided thresholds by about 10 dB on average. Gurgel
and Shelton (2013) have shown that the SoundBite is safe and effective for SSD
patients over 6 months usage of the device in 34 patients. Acoustic feedback has
been reported to be the most common problem with the SoundBite, but has been
minimized with proper fitting. The inclusion criteria for the SoundBite has been a
four tone pure tone average (PTA) of less than 25 dB HL in the better hearing ear
with no air bone gap, and no measurable hearing or PTA greater than 75 dB HL
in the poorer hearing ear.
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Chapter 4
Summary of Papers
4.1 Engineering aspects and preclinical
studies of the BCI (Paper I)
The aim of this feasibility study (Paper I) was to describe the basic engineering
principles of a new bone conduction implant (BCI) system and investigate if it
could provide enough output power. Laser Doppler vibrometer (LDV) measure-
ments was performed on three cadaver heads and it was found that the new BCI
system produced 0-10 dB higher maximum output acceleration level at the ipsi-
lateral promontory relative to conventional ear-level bone anchored hearing aid
(BAHA) at speech frequencies. At the contralateral promontory the maximum
output acceleration level was considerably lower for the BCI than for the BAHA.
In short, when comparing the ”acoustically” generated frequency responses be-
tween the different devices only the maximum power output (MPO) gives an ad-
equate comparison of the potential capacity of the systems. At levels below the
MPO the response curves in each device can be changed by amplifier settings in a
multitude of ways. Therefore, only the MPO velocity difference (BCI vs. Baha R©
Classic and BCI vs. Baha R© Intenso) at the ipsilateral and contralateral sides were
calculated as the average among the subjects. The results are presented in Figure
4.1. The improvements (red area) in acoustic response curves at MPO (average
among the three subjects) indicate what could be experienced by the patients re-
garding maximum loudness differences between the devices. Hence it seems from
ipsilateral measurements that the BCI will be 5-10 dB stronger than the Baha R©
Classic and 0-5 dB stronger than the Baha R© Intenso for frequencies of 700 Hz to
7 kHz. At the contralateral side, however, it was found that the BCI produced a
considerably lower MPO than the Baha R© Classic as well as the Baha R© Intenso.
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Figure 4.1: Ipsilateral and contralateral average (three subjects) MPO difference as BCI
vs. Baha R© Classic (left), and BCI vs. Baha R© Intenso (right).
4.2 Analog RF data and power link design
(Paper II)
In a first implementation for the bone conduction implant (BCI), an analog radio
frequency (RF) data and power link was designed. The RF link is designed to
operate in critical coupling to transmit maximum power to the implant using am-
plitude modulation (AM). Maximum power output (MPO) of the BCI was mea-
sured at 2 mm skin thickness and was found to be 105 dB relative to 1 µN at the
transducer resonance frequency. This output force was fairly robust in 2 to 6 mm
skin thickness range.
Consequently, Figure 4.2 presents a MPO comparison of the BCI with existing
bone conduction devices, the Baha R© Classic 300, the Baha R© Intenso and a mid-
dle ear implant audio processor (Vibrant Soundbridge, MEDEL) driving a naked
transducer of balanced electromagnetic separation transducer type. A 2 mm coil
spacing was used in the BCI and the MEDEL measurements. Most importantly,
the BCI with the analog RF drive can generate the same MPO as the MEDEL
device that uses some kind of switching drive circuit topology. Both devices use
RF links that keeps the skin intact whereas the Intenso and Classic 300 are percu-
taneous bone anchored devices as they are directly coupled to the skull bone. By
comparing the BCI with Classic 300, it can be concluded that this first RF link de-
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Figure 4.2: Comparison of output force level between implantable bone conduction de-
vices when measured on a Skull simulator.
sign results in a loss of 10-15 dB in the output force of the device when measured
on a Skull simulator. On the other hand it was shown by Ha˚kansson et al. (2008)
and in Paper I, measuring with laser Doppler vibrometer on cadaver heads that
the sensitivity to bone conducted sound increases with the same amount or more
when the excitation point of the device moves to a position closer to the cochlea,
which is the case in the BCI.
Even though this design could produce the highest possible output force level
and a reasonable robust power transmission for different skin thicknesses, several
filters and AM circuitry had a current consumption that was too high and the
robustness to the skin thickness variation was not satisfactory. However, more
efficient RF power amplifier could be designed using switching topology such as
Class-E that was investigated in Paper III.
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4.3 Class-E switching RF data and power link
design (Paper III)
This paper presents an improved design of a radio frequency power and data link
for a full bone conduction implant (BCI) system. The BCI comprises an external
audio processor unit with a transmitter coil and an implanted unit called the bridg-
ing bone conductor with a receiver coil. Using amplitude modulation of the Class-
E power amplifier that drives the inductive link, the sound signal is transmitted to
the implant through the intact skin. It was found that the BCI can generate enough
output force level (OFL) for candidate patients. The acoustical performance of the
BCI device is shown in Figure 4.3(a).
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Figure 4.3: (a) Output force levels measured at 60, 70 and 90 dB SPL. MPO curves were
measured where the coil spacing was varied from 1 to 8 mm. Highest MPO occurs in the
4 mm skin thickness. The noise floor curve shows that the measurements were done with
a high SNR. Between 4-5 kHz the BEST transducer has a second resonance frequency to
boost the high frequency response. (b) The sound pressure was kept fairly constant during
the entire frequency sweep (±0.5 dB).
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OFL of the BCI was measured at 60, 70 and 90 dB SPL where the 60 and 70
dB SPL curves revealed that the device is linear as 10 dB increase in the input
sound pressure level results in 10 dB increase in the output force level. The most
important curve is the maximum power output (MPO) when the device is saturated
and limited by the battery voltage capacity at the output. MPO of the BCI was
designed to occur at 5 mm skin thickness. The power output variability was within
1.5 dB for 1 to 8 mm skin thickness variations. The battery current consumption
of the BCI was 14.6 mA at 1 kHz and 65 dB input sound pressure level (SPL). It
is illustrated that the new BEST design has the high frequency boost that can be
beneficial for speech understanding. Furthermore, it is illustrated in Figure 4.3(b)
that the input sound pressure to the microphone was fairly constant and changing
only ±0.5 dB in the entire frequency sweep.
This design was sufficiently insensitive to skin flap thickness variations in the
power transmission to the implant, but still had a high current consumption, basi-
cally because of high quiescent current in the control and filter circuits. In order
to further reduce current consumption, a switching power amplifier can be de-
signed in an ultra-low power ASIC that includes a half-bridge Class-D switching
topology. This was investigated in Paper VI.
4.4 Feedback Analysis in the BAHA and the BCI
(Paper IV)
The hypothesis in this study was that the bone conduction implant (BCI) can use
a higher gain setting without feedback problems as compared with a percutaneous
bone anchored hearing aid (BAHA). It was experienced in previous cadaver stud-
ies by Ha˚kansson et al. (2008) and in Paper I that the BCI is less prone to fall into
feedback oscillations thus allowing more high frequency gain. It should be noted
that the notation PBCD (stands for percutaneous bone conduction device) is used
in some US journals synonymous to the BAHA mainly for reimbursement issues.
In this study, loop gains of the Baha R© Classic 300 (a BAHA with linear ampli-
fication from Cochlear Bone Anchored Solutions, Mo¨lnlycke, Sweden) and the
BCI were measured in the frequency range of 100 Hz to 10 kHz with the devices
attached to a dry skull. The BAHA and the BCI positions were investigated. The
devices were adjusted to Full-on Gain (factory preset maximum volume control
setting). It was found that the gain headroom using the BCI was generally 0-10
dB better at higher frequencies than using the BAHA for a given mechanical out-
put. More specifically, if the mechanical output of the devices were normalized
at the cochlear level, the improvement in gain headroom with the BCI versus the
BAHA was in the range of 10-30 dB. It was concluded that when using a BCI, a
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significantly higher gain setting can be used without feedback problems as com-
pared with using a BAHA. In the overall analysis, Figure 4.4 shows the BAHA
loop gain and the BCI loop gain compensated for the same mechanical output and
to give the same cochlear acceleration as the BAHA. It can be observed that the
compensated BCI for the same cochlear acceleration level has 10-30 dB higher
gain headroom than the BAHA in the range of 600 to 7500 Hz, and 17 dB (20 vs.
3 dB) at the most critical frequency. The improved gain headroom indicates how
much the amplification can be increased with the BCI device, as compared with
the BAHA, without obtaining feedback oscillations.
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Figure 4.4: The BAHA and the compensated BCI loop gain magnitudes on dry skull. BCI
compensations were done to obtain the same cochlear acceleration level as the BAHA.
4.5 Flat surface contact of a BCI transducer in vivo
(Paper V)
The hypothesis in this study was that the bone conduction implant (BCI) attached
with a flat surface contact will offer efficient and linear vibration transmission
over time. In the BCI, the vibrations are transmitted through the flat surface of the
titanium casing of the transducer in contact with the skull bone instead of using
screw attachment that is the case in the bone anchored hearing aids. In this study,
BCI dummy implants were installed in three sheep skulls in vivo to study the
vibration transmission characteristics over time. Mechanical point impedances
and vibration transfer response functions of the BCI implants were measured at
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the time of surgery and after a healing period of 8 months. In one sheep, both
implants healed without complications. In the other two sheep, the implants were
either partially loose or lost to follow up. In the sheep with stable implants, it was
found by the resonance frequency shift of the mechanical point impedance that a
firmer integration between the implant and bone tissue as seen in osseointegrated
surfaces developed over time. It was also shown that the transcranial vibration
transmission remains stable over time and linear for the different level tested. No
significant influence of using bone chips was seen in the transfer response function
and promotion of osseointegration after the relative short period of 8 months. The
surgical procedure for installing the BCI dummy implants was uneventful.
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Figure 4.5: Magnitude of the mechanical point impedance curves for stable sheep, left
and right sides in stages 1 and 2. BCI was installed with bone chips on the left side.
As a result, Figure 4.5 shows the magnitude of the mechanical point impedance
measured at both implants (left and right sides) of the stable sheep. The impedances
were measured at 60 dB hearing level excitation force and for stages 1 (at implan-
tation) and 2 (after 8 months healing). It can be seen that the resonance frequency
in the low frequency range of the magnitude curve is slightly moved to a higher
frequency in stage 2. This implies that a more rigid contact between implant and
the bone surface has developed at stage 2. This is further strengthened by a gen-
erally increased magnitude level for frequencies above the resonance frequency
after the healing period.
It was concluded that the mechanical point impedances and vibration trans-
fer response functions indicate that the BCI implants integrate and transmission
conditions remain stable over time.
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4.6 Technical design of the BCI system (Paper VI)
The objective in this paper is to describe the technical design aspects of a new
Bone Conduction Implant (BCI) system that has been designed and developed for
long-term use in a clinical study on real patients. An evaluation of the full BCI
system has been performed on a Skull simulator, cadaver heads, and on patients.
In addition, a nasal sound pressure measurement was used as an intraoperative
method to verify that the implant operates properly before closing the incision.
It was found that the output force of the BCI is robust for skin thickness range
of 2-8 mm and total harmonic distortion is low in the speech frequency range.
The current consumption is low and corresponds to 5-7 days use with a single
battery. The performance and verification tests show that the BCI has sufficient
output for hearing rehabilitation of indicated patients. The patients wear the de-
vice conveniently and use it in their everyday life without any skin problem. The
intraoperative verification method shows that the implant performs as expected
and can also be used to follow the implant on a longer term.
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Figure 4.6: Output force levels (OFL) measured at equalized 60, 70 and 90 dB input SPL
and the total harmonic distortion (THD) measured at 70 dB SPL at 5 mm skin thickness.
Maximum power output (MPO) when the skin flap thickness was varied from 2 to 8 mm.
The highest MPO occurs at 5 mm skin thickness, which was the optimal design target.
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In the overall analysis, Figure 4.6 shows the acoustical performance of the
BCI measured on a Skull simulator. The output force level (OFL) of the BCI
was measured at 60, 70 and 90 dB SPL, where the 60 and 70 dB SPL curves
indicate that the device is linear as 10 dB increase in the input SPL results in 10
dB increase of the OFL. The most important curve is the maximum power output
(MPO) measured at 90 dB SPL when the device is saturated and limited by the
battery voltage capacity at the output. The MPO was also measured for different
skin flap thicknesses. It can be seen in Figure 4.6 that the MPO will changes
only 1.5 dB over the skin flap thickness variations of 2 to 8 mm. It is shown by
the OFL graphs that the Balanced Electromagnetic Separation Transducer (BEST)
design has the main resonance peak at around 750 Hz and also an additional high
frequency resonance at around 4.5 kHz. Furthermore, the gray area under OFL
curves shows the total harmonic distortion of the BCI device when the input was
70 dB SPL with a skin thickness of 5 mm. The input sound pressure levels to the
microphone were equalized and within ±2 dB in the entire frequency range.
It was concluded that the BCI design using Class-D is a robust design that
offers a sufficient high output and an excellent signal quality for the hearing reha-
bilitation of indicated patients.
4.7 First implantation, surgical and audiological
aspects of the BCI (Paper VII)
The objective of this study was to report preoperative assessment, surgery, and
audiological outcome of the first patient implanted with the bone conduction im-
plant (BCI). The first patient to receive a BCI was a 42 years old woman with
a unilateral mixed hearing loss due to tympanosclerosis. Preoperative and post-
operative cone beam computed tomography and a virtual planning tool for 3D
reconstruction were used to optimize and control the position of the BCI in the
mastoid. The transducer was placed in an approximately 5 mm deep seating in
the mastoid and secured with a titanium bar. Sound field tone and speech audiom-
etry were conducted to evaluate the audiological outcome at baseline (at fitting of
audio processor, 1 month post operatively) and 1 month after baseline. The BCI
was placed in position according to the preoperative 3D planning.
On average after one month, the tone thresholds improved by 30 dB (Fig-
ure 4.7) and speech reception thresholds by 25.5 dB. It was also concluded that
the present BCI device can provide hearing rehabilitation in patients with mild to
moderate conductive or mixed hearing losses. The surgical procedure on the first
BCI patient was found to be uncomplicated and safe. 3D preoperative planning
can be a helpful tool to optimize the BCI position, but might not be needed in
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1 month
Figure 4.7: Sound field hearing thresholds for the 2 conditions: unaided and aided with
the BCI device.
patients with normal anatomy. More patients have to be operated and followed
for longer time before more detailed indications and contraindications can be es-
tablished.
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Chapter 5
Conclusions and future work
The bone conduction implant (BCI) has been designed and developed to be used
for long-term implantation in patients with conductive and mixed hearing loss.
The major advantage of the BCI over the established percutaneous bone anchored
hearing aid (BAHA) is that the BCI leaves the skin and subcutaneous tissue intact.
It has been concluded that:
• the first prototype BCI is sufficiently powerful as compared to percutaneous
BAHA,
• the BCI can generate high enough output force levels for indicated patients
with a sufficiently low total harmonic distortion. An efficient inductive link
was designed with the output power robust to skin flap thickness variations
(107 dB re 1µN at 5 mm with 1.5 dB variability over the range of 2-8 mm
skin thickness),
• the BCI had an improved gain headroom of 10-30 dB relative to the BAHA,
if the mechanical output of the devices were normalized at the cochlear
level. The gain headroom improvement at the most critical frequency in
each device was 17 dB. The improved gain headroom will allow for a pos-
sibility to increase the real gain of the BCI as compared to the BAHA,
• stability of dummy BCI implants improved during the healing period in an
animal study, which indicates that more bone contact was developed over
time. The vibration transmission was stable and linear over time and no
significant influence of using bone chips was seen in vibration transmission
and promotion of osseointegration after 8 months,
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• the full BCI system that was developed was powerful and stable enough
with low distortion to be used in patients. The battery drain of the BCI is
acceptable and the battery will last for 5-7 days based on patient use, and
• the BCI can provide hearing rehabilitation in patients with mild-to-moderate
conductive or mixed hearing losses. The surgical procedure on patients was
found to be safe and uncomplicated.
In Fall 2012, approvals from Swedish Medical Agency and the Regional Ethics
Committee were achieved for treating up to 20 patients with the BCI. A first pa-
tient was operated in December 2012 and is reported in this thesis, but today six
patients have undergone surgery for the BCI.
In future work, finalizing this clinical study is required in order to establish a
more reliable indication range of the BCI, to improve the surgical methods, and
to investigate the long-term audiological outcomes and the patient safety aspects.
Investigations are also needed to compare the audiological outcomes of the
BCI with other bone conduction devices like the percutaneous BAHA. It is also
very important to continue the follow-ups in order to conclude about the long-term
implant performance, using the nasal sound pressure and cone beam computed
tomography.
Magnetic Resonance Imaging (MRI) examinations need to be studied more
carefully. Any adverse effects by MRI on the patient, on the implant, and on
the generated image need to be clarified. Possible solutions to minimize these
adverse effects in the BCI will be studied with the purpose to have a conditional
MRI approval for up to 1.5 Tesla.
The most important next steps of the BCI project are to apply for CE mark
based on the information from the clinical study and to expand the implantations
internationally.
In technical terms, to adaptively reduce power consumption of the audio pro-
cessor in quieter sound environments and to improve the modulation technique
should be persued. Moreover, the requirements for stronger BCI device can be
investigated by use of the radio frequency carrier signal to produce internal power
supply in the implanted unit to drive the transducer, which may give higher output
force levels. This solution can be implemented by an implanted power amplifier
design to actively drive the transducer.
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